PMDA drug package insert
マーズレン配合錠0.375ES
PMDA Prescription drug · 寿製薬株式会社 · package insert Dec 4, 2025
Key facts
| Brand names | マーズレン配合錠0.375ES, マーズレン配合錠0.5ES, マーズレン配合錠1.0ES |
|---|---|
| Nonproprietary names | アズレンスルホン酸ナトリウム水和物・Ｌ－グルタミン |
| Companies | 製造販売元／寿製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 胃炎・消化性潰瘍治療剤 |
| Therapeutic category codes | 872329 |
| YJ codes | 2329122F3027, 2329122F2020, 2329122F1032 |
| Approval numbers | 22100AMX01901000, 22000AMX01185000, 22000AMX01863000 |
| Package insert date | Dec 4, 2025 |
| PMDA document key | 270139_2329122F1032_1 |
| PMDA company code | 270139 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: